EVEREST MED.LTD DL-0001 (F:6HN) — Stock Price

€3.02 EUR
▼ -1.31% today

EVEREST MED.LTD DL-0001 (F:6HN) is currently trading at €3.02 EUR, down 1.31% today. Over the past 52 weeks, shares have ranged between €2.48 and €6.25. This page tracks EVEREST MED.LTD DL-0001's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. To see how efficiently this company converts equity into cash flow, see EVEREST MED.LTD DL-0001 cash flow conversion.

EVEREST MED.LTD DL-0001 (6HN) Stock Price Chart — Daily History & Trading Volume

The chart below tracks EVEREST MED.LTD DL-0001's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.

EVEREST MED.LTD DL-0001 Income Statement — Revenue, Profit & Earnings by Year

EVEREST MED.LTD DL-0001's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.

Fiscal Year 20252024202320222021
Total Revenue €1.71 Billion €706.68 Million €125.93 Million €12.79 Million €54.00K
Cost of Revenue €524.77 Million €179.79 Million €34.41 Million €4.64 Million €23.00K
Gross Profit €1.18 Billion €526.88 Million €91.52 Million €8.15 Million €31.00K
Research & Development €511.04 Million €528.03 Million €540.05 Million €809.74 Million €613.43 Million
SG&A €1.06 Billion €758.15 Million €396.57 Million €603.23 Million €440.83 Million
Total Operating Expenses €2.08 Billion €1.45 Billion €957.87 Million €1.41 Billion €1.05 Billion
Operating Income €-370.67 Million €-743.90 Million €-831.93 Million €-1.40 Billion €-1.05 Billion
EBITDA — — — — —
EBIT — — — — —
Interest Expense €23.27 Million €22.19 Million €23.06 Million €5.59 Million €4.82 Million
Income Before Tax €-598.36 Million €-1.04 Billion €-844.46 Million €-247.28 Million €-1.01 Billion
Income Tax Expense — — — — —
Net Income €-297.77 Million €-1.04 Billion €-844.46 Million €-247.28 Million €-1.01 Billion

EVEREST MED.LTD DL-0001 Balance Sheet — Assets, Liabilities & Shareholder Equity

The balance sheet below summarizes EVEREST MED.LTD DL-0001's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.

Fiscal Year 20252024202320222021
Total Assets €6.83 Billion €4.96 Billion €5.77 Billion €6.61 Billion €6.65 Billion
Total Current Assets €3.37 Billion €2.02 Billion €2.51 Billion €3.41 Billion €2.69 Billion
Cash & Equivalents — — — — —
Short-term Investments €887.09 Million €718.84 Million €1.83 Billion €1.16 Billion —
Net Receivables €500.02 Million €363.57 Million €49.86 Million €5.21 Million €49.00K
Inventory €32.22 Million €14.08 Million €18.94 Million €11.64 Million €447.00K
Property, Plant & Equipment — — — — —
Goodwill — — — — —
Total Liabilities €1.53 Billion €886.05 Million €804.10 Million €960.25 Million €753.83 Million
Total Current Liabilities €689.61 Million €793.54 Million €328.74 Million €900.95 Million €270.27 Million
Long-term Debt €792.12 Million €55.85 Million €429.31 Million €0.00 €360.93 Million
Net Debt — — — — —
Total Stockholder Equity €5.30 Billion €4.07 Billion €4.97 Billion €5.65 Billion €5.89 Billion
Retained Earnings €-10.55 Billion €-10.06 Billion €-9.02 Billion €-8.17 Billion €-7.92 Billion

EVEREST MED.LTD DL-0001 Cash Flow Statement — Operating, Investing & Financing Activities

This cash flow statement breaks down how EVEREST MED.LTD DL-0001 generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.

Fiscal Year 20252024202320222021
Operating Cash Flow €-92.56 Million €-679.51 Million €-769.19 Million €-1.16 Billion €-729.94 Million
Capital Expenditures €348.34 Million €204.15 Million €265.95 Million €432.74 Million €975.82 Million
Free Cash Flow €-440.90 Million €-883.66 Million €-1.04 Billion €-1.59 Billion €-1.71 Billion
Investing Cash Flow — — — — —
Financing Cash Flow — — — — —
Dividends Paid — — — — —
Stock-Based Compensation €131.78 Million €91.10 Million €73.42 Million €206.50 Million €224.98 Million
Depreciation €156.52 Million €133.62 Million €76.78 Million €42.77 Million €31.12 Million
Change in Cash €987.43 Million €332.68 Million €-6.59 Million €-2.15 Billion €-1.84 Billion

EVEREST MED.LTD DL-0001 Earnings History — EPS Actual vs. Analyst Estimates

Track EVEREST MED.LTD DL-0001's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.

Report Date EPS Actual EPS Estimate Surprise
Mar 25, 2027 — — —
Aug 18, 2026 — — —
Mar 25, 2026 — — —
Aug 28, 2025 — — —
Mar 25, 2025 — — —